Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.
Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, Yao L, Liu H, Barahmand-pour F, Sivakumar P, Chan C, Birks C, Foster D, Clegg CH, Wietzke-Braun P, Mihm S, Klucher KM.
Doyle SE, et al.
Hepatology. 2006 Oct;44(4):896-906. doi: 10.1002/hep.21312.
Hepatology. 2006.
PMID: 17006906